Hepatitis C Community
canabis
About This Community:

This forum is for questions about medical issues and research aspects of Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new Hepatitis Social/Living with Hepatitis forum

Font Size:
A
A
A
Background:
Blank
Blank
Blank
Blank Blank

canabis

Journal of Hepatology
Volume 48, Issue 4, April 2008, Pages 657-665

Environmental factors as disease accelerators during chronic hepatitis C

Ariane Mallat, a, b, c, , Christophe Hezodea, b, c and Sophie Lotersztajna,
b, c

A Department of Hepatology and Gastroenterology, INSERM U841, Groupe
hospitalier Henri Mondor-Albert Chenevier, Créteil F-94000, France
B AP-HP, Groupe hospitalier Henri Mondor-Albert Chenevier, Service
d’Hépatologie et de Gastroentérologie, Créteil F-94000, France
C Université Paris 12, Faculté de Médecine, Créteil F-94000, France

Corresponding author.
Tel.: +33 (0) 1 49 81 23 67;
fax: +33 (0) 1 49 81 23 52.
ariane.***@****

Keywords: Alcohol; Tobacco; Hepatitis C virus; Chronic hepatitis C;
Cannabis; CB1 receptor; CB2 receptor; Cannabinoid

Progression of chronic hepatitis is highly variable among individuals, as
the result of several host, viral and environmental factors.
The latter have been extensively investigated in order to ameliorate
hepatitis C outcome, particularly in difficult-to-treat patients.
Over the last decade, several studies have shown that a combination of HCV
infection and high levels of alcohol abuse results in synergistic
acceleration of liver fibrogenesis.
In addition, recent data indicate that light alcohol intake may also
exacerbate fibrosis progression.
It has also been suggested that cigarette smoking may enhance activity grade
in patients with chronic hepatitis C, thereby increasing progression of
fibrosis.
This assumption mostly relies on epidemiological evidences in the absence of
pathogenic studies.
Finally, cannabis use is increasingly emerging as a novel co-morbidity in
patients with chronic hepatitis C.
Indeed, regular cannabis smoking is an independent predictor of both
fibrosis and steatosis severity in infected patients.
In addition, experimental studies have shown that cannabinoid CB1 receptors
enhance liver fibrogenesis and steatogenesis by distinct mechanisms,
therefore strongly supporting epidemiological findings.
Altogether, patients should be informed of the deleterious impact of
alcohol, tobacco and cannabis use and should be offered appropriate support
to achieve abstinence.

Related Discussions
190885_tn?1333029491
i don't know about the post but your profile cracked me up......i think a little pot isn't that bad...what about other pollution like from cars ..carpets...coal plants...bad water supply..and bombs....billy
Blank
Post a Comment
To
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis C Community Resources
RSS Expert Activity
469720_tn?1388149949
Blank
Abdominal Aortic Aneurysm-treatable... Blank
Oct 04 by Lee Kirksey, MDBlank
242532_tn?1269553979
Blank
The 3 Essentials to Ending Emotiona...
Sep 18 by Roger Gould, M.D.Blank
242532_tn?1269553979
Blank
Control Emotional Eating with this ...
Sep 04 by Roger Gould, M.D.Blank
Top Hepatitis Answerers
Avatar_f_tn
Blank
Livelife777
683231_tn?1415953923
Blank
flyinlynn
Auburn, WA
163305_tn?1333672171
Blank
orphanedhawk
Rural Mural, CA
446474_tn?1404424777
Blank
HectorSF
CA
96938_tn?1189803458
Blank
FlGuy
South, FL
Avatar_f_tn
Blank
dontworry_behappy1
CA